QuartataWeb 1.0

Data source: DrugBank-all; Query type: target; # of requested predictions: 20; Secondary interactions: no
Input target 1: P10253

No. Gene UniProt ID Protein Name Pathway PDB

1 GAA P10253 Lysosomal alpha-glucosidase hsa00052; hsa00500; hsa01100; hsa04142 NA

3 known interactions (drugs) of input target (GAA): Lysosomal alpha-glucosidase

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter
1	Investigational	SmallMoleculeDrug	DB05200	AT2220	NA
2	Approved	SmallMoleculeDrug	DB00491	Miglitol	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
3	Approved; Investigational	SmallMoleculeDrug	DB00284	Acarbose	[H][C@@](O)(CO)[C@@]([H])(O[C@@]1([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(C)[C@@]([H])(N[C@@]3([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O)[C@]([H])(O)[C@@]([H])(O)C=O

20 predicted interactions (drugs) of input target (GAA): Lysosomal alpha-glucosidase

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter	Confidence score
1	Approved; Investigational	SmallMoleculeDrug	DB04878	Voglibose	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	22.5%
2	Approved; Investigational	SmallMoleculeDrug	DB01593	Zinc	[Zn]	21.6%
3	Approved; Investigational; Vet approved	SmallMoleculeDrug	DB01110	Miconazole	ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1	20.7%
4	Approved; Nutraceutical; Vet approved	SmallMoleculeDrug	DB00162	Vitamin A	C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C	18.6%
5	Approved; Investigational	BiotechDrug	DB00005	Etanercept	NA	17.5%
6	Approved; Investigational	BiotechDrug	DB00056	Gemtuzumab ozogamicin	NA	16.4%
7	Approved	SmallMoleculeDrug	DB00457	Prazosin	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1	16.3%
8	Approved; Vet approved	SmallMoleculeDrug	DB01159	Halothane	FC(F)(F)C(Cl)Br	16.3%
9	Approved; Investigational; Nutraceutical	SmallMoleculeDrug	DB01708	Prasterone	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C	16.1%
10	Approved; Investigational	BiotechDrug	DB00095	Efalizumab	NA	15.9%
11	Approved	BiotechDrug	DB00054	Abciximab	NA	15.4%
12	Approved	SmallMoleculeDrug	DB00493	Cefotaxime	[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O	15.4%
13	Experimental	SmallMoleculeDrug	DB04315	Guanosine-5'-Diphosphate	NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1	15.3%
14	Investigational; Withdrawn	BiotechDrug	DB00111	Daclizumab	NA	15.0%
15	Experimental	SmallMoleculeDrug	DB04400	L-erythro-7,8-dihydrobiopterin	[H][C@@](C)(O)[C@]([H])(O)C1=NC2=C(NC1)NC(=N)N=C2O	14.4%
16	Investigational	SmallMoleculeDrug	DB12548	Sparsentan	CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C(COCC)=C1)C1=CC=CC=C1S(=O)(=O)NC1=NOC(C)=C1C	14.2%
17	Approved; Investigational	BiotechDrug	DB00075	Muromonab	NA	14.1%
18	Experimental	SmallMoleculeDrug	DB04327	Phosphatidylethanolamine	CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC	14.0%
19	Approved	BiotechDrug	DB00002	Cetuximab	NA	13.9%
20	Approved; Investigational	BiotechDrug	DB00074	Basiliximab	NA	13.7%